Home : October 2012 : October 05, 2012 News : Cell Therapeutics Prices Underwritten Public Offering of $60 Million of Convertible Preferred Stock

Cell Therapeutics Prices Underwritten Public Offering of $60 Million of Convertible Preferred Stock

October 05, 2012

SEATTLE, Oct. 5, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced the pricing of an underwritten public offering of 60,000 shares of its Series 17 Preferred Stock, offered at a price to the public of $1,000 per share of Series 17 Preferred Stock...

http://www.prnewswire.com/news-releases/cell-therapeutics-prices-underwritten-public-offering-of-60-million-of-convertible-preferred-stock-172774851.html
Other Stories